XML 213 R55.htm IDEA: XBRL DOCUMENT v3.21.2
Net Income (Loss) Per Common Share - Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share (Detail) - shares
shares in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total number of potentially issuable shares (in shares) 18,504 25,091 18,310 21,060
Options to purchase common stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total number of potentially issuable shares (in shares) 6,478 7,157 6,348 5,386
Convertible Notes due 2020        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total number of potentially issuable shares (in shares) 0 3,983 0 3,983
Common stock issuable under the 2024 notes        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total number of potentially issuable shares (in shares) 3,970 3,970 3,970 3,970
Common stock issuable under the 2027 Notes        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total number of potentially issuable shares (in shares) 4,365 4,365 4,365 4,365
Unvested RSUs        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total number of potentially issuable shares (in shares) 3,349 4,832 3,290 3,099
Common stock potentially issuable for ESPP purchases        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total number of potentially issuable shares (in shares) 342 574 337 257